Likewise, kinase inhibitors that block PDGFRA—ripretinib, avapritinib, and crenolanib—are used, and different combinations of these drugs in GIST treatment have been proposed [72,73]. Here, PDGFRA is linked to gastrointestinal stromal tumor.